14April

Novo Nordisk extends programme for children with diabetes in developing countrie ... Read more

10April

Novo Nordisk opens new insulin formulation and filling facility in Russia ... Read more

07April

US FDA accepts Tresiba® and Ryzodeg® resubmissions for review ... Read more

26March

Novo Nordisk has decided to resubmit the New Drug Applications of Tresiba® and R ... Read more

13April

Novo Nordisk A/S - Share repurchase programme ... Read more

07April

US FDA accepts Tresiba® and Ryzodeg® resubmissions for review ... Read more

01April

Novo Nordisk A/S: Status regarding Novo Nordisk's holding of its own shares (31 ... Read more

01April

Novo Nordisk A/S - Share repurchase programme ... Read more

30April

Financial statement for the first three months of 2015,

04May

Q1 roadshow, Europe

04May

Q1 roadshow, North America

07May

Deutsche Bank Healthcare Conference, Boston

 

 

 

Investors

 
Share information


Take an advanced view of the Novo Nordisk share

Read more

 
IR material


Download relevant Investor Relations material

Read more

 
Financial results


See the full-year 2014 financial statement

Read more



Novo Nordisk at a glance


Read about Novo Nordisk – A focused healthcare company

Read more



Private shareholders


See relevant content for private investors

Read more



Annual report


Download the Novo Nordisk Annual Report

Read more



Contacts



Subscriptions


Sign up and follow Novo Nordisk Investors Relations



Q1 2015 release


See info on the conference call following the Q1 2015 release